UTHR Description — United Therapeutics Corp

United Therapeutics is a biotechnology company. Co. markets and sells four commercial therapies in the U.S. to treat pulmonary arterial hypertension: Tyvaso® (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin® (treprostinil) Injection (Remodulin); Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, which is approved for treatment of high-risk neuroblastoma, and the Remunity® Pump for Remodulin.

Company Name: 
United Therapeutics Corp
Number of ETFs Holding UTHR: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   UTHR Weight   UTHR Amount 
 VTI   0.02%   $308,931,976         
 IJH   0.47%   $308,465,215         
 VB   0.22%   $261,527,173         
 VBR   0.39%   $184,684,100         
 VXF   0.16%   $137,165,910         
 MDY   0.47%   $87,839,684         
 IJK   0.92%   $67,014,904         
 XBI   0.95%   $61,128,659         
 FBT   2.99%   $43,446,366         
 VHT   0.18%   $35,019,139         
List of all 82 ETFs holding UTHR »
Quotes delayed 20 minutes

Email EnvelopeFree UTHR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.42 out of 4)
52nd percentile
(ranked higher than approx. 52% of all stocks covered)

Analysts Forecast:
UTHR Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding UTHR | United Therapeutics Corp | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.